MERRIMACK PHARMACEUTICALS INC Total Liabilities
MERRIMACK PHARMACEUTICALS INC had Total Liabilities of $22.67 million as of 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2024-05-15
- 2024-03-31: Liabilities $22.67M.
- 2023-12-31: Liabilities $441.00K.
- 2023-09-30: Liabilities $493.00K.
- 2023-06-30: Liabilities $411.00K.
| Period end | Liabilities | Liabilities as first filed |
|---|---|---|
| 2024-03-31 | $22.67M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $441.00K 10-Q · filed 2024-05-15 | |
| 2023-09-30 | $493.00K 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $411.00K 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $463.00K 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $589.00K 10-K · filed 2024-03-07 | |
| 2022-09-30 | $448.00K 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $441.00K 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $564.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $562.00K 10-K · filed 2023-03-09 | |
| 2021-09-30 | $683.00K 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $772.00K 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $684.00K 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $770.00K 10-K · filed 2022-03-09 | |
| 2020-09-30 | $2.22M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $2.33M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $3.30M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $2.77M 10-K · filed 2021-03-10 | |
| 2019-09-30 | $4.74M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $5.00M 10-Q · filed 2019-07-17 | |
| 2019-03-31 | $25.39M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $29.72M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $36.87M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $17.95M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $18.24M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $21.04M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $86.21M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $108.97M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $345.78M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $334.14M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $345.55M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $351.58M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $410.07M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $418.57M 8-K · filed 2017-12-15 | |
| 2015-09-30 | $243.35M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $248.11M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $255.84M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $260.58M 10-K · filed 2016-02-26 | $260.73M 10-K · filed 2015-02-27 |
| 2014-09-30 | $288.47M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $206.94M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $230.78M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $235.54M 10-K · filed 2015-02-27 | |
| 2013-09-30 | $240.88M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $165.66M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $159.46M 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $155.39M 10-K · filed 2014-03-04 | |
| 2012-09-30 | $110.19M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $105.62M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $108.05M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $106.99M 10-K · filed 2013-03-20 |